Similar results were obtained upon ectopic expression of miR-205 in another HER2+ BC cell line (BT474), corroborating the hypothesis that miR-205 can modulate trastuzumab response in the HER2+ subgroup of BC (Supplementary Figure 2). This evidence concerns the gene ERBB2 and breast cancer.